Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…<p>Odds ratios (OR) and 95% confidence intervals of SLE and MS cohorts. For all graphs, the dotted line represents an OR of 1.0. …”

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity by Qin Huang (49441)

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. by Bert Baumgaertner (3595814)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Decrease in loss during the training process. by Muhammad Idrees (92773)

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…Activity rates decreased during repeated stress compared to baseline (2-way ANOVA, condition F = 185.6, <i>p</i> = 4.8 × 10⁻⁴², condition: intensity interaction F = 10.37, <i>p</i> = 9.3 × 10⁻²¹, nested ANOVA (mouse nested within session), condition F = 174, <i>p</i> = 1.5 × 10⁻³⁹, condition: intensity interaction F = 12.7, <i>p</i> = 2 × 10⁻²⁶, post hoc for each level baseline versus repetitive stress <i>p</i> < 0.01 for all levels above 50 dB, all Bonferroni corrected). …”

Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

Decreased test sensitivity: Screening the whole population. by Timo de Wolff (9904467)

PNs, ORNs and LNs response to a short (50 ms) pulse, similar results of Fig 4. by Mario Pannunzi (553941)

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

“…(B) In the hippocampus, we observed decreased PrP^Res, GFAP and vacuolation in responder and non-responder mice compared to infected untreated mice. …”

Atherosclerosis is associated with a decrease in cerebral microvascular blood flow and tissue oxygenation by Baoqiang Li (1610221)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

Knockdown of FZD10 results in a decrease in cell proliferation in the neural tube. by Abdulmajeed Fahad Alrefaei (8968607)

“…(F) Quantification of the number of pH3 positive cells per section in the neural tube electroporated with FZD10 shRNA vector compared to the non-electroporated side showed that there was a statistically significant decrease in the number of pH3 positive cells (students t-test (paired)).…”

Decreased Incidence of Type 1 Diabetes in Young Finnish Children by Anna Parviainen (9343391)

“…We assessed sex-specific incidence rates (IRs) per 100,000 person years (PY) by 4-year time periods in three age groups (0.50–4.99, 5.00–9.99, and 10.00–14.99 years).…”

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)